B22 - comprehensive in vitro antiviral screening against BSL-4 pathogens.
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $540,000
Award facts
- Contract value 65% obligated
-
- $540,000.00 Current, with exercised options
- $825,935.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
Utah State University was awarded an $825,935 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) master indefinite delivery contract held with the National Institutes of Health National Institute of Allergy and Infectious Diseases. The order is for comprehensive in vitro antiviral screening against biosafety level 4 pathogens through March 2025. No set aside designation was utilized for this award. Utah State University will leverage its expertise conducting animal disease testing and assessments of antimicrobial activity to provide specialized virus screening services in support of the National Institute of Allergy and Infectious Diseases' research into highly pathogenic organisms.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 13, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $540,000 on 75N93024F00001. Its potential value, with all options, is $825,935.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award